8C4 Stock Overview
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
CYBERDYNE Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1.27 |
52 Week High | JP¥2.22 |
52 Week Low | JP¥1.21 |
Beta | 0.56 |
1 Month Change | 3.25% |
3 Month Change | -1.55% |
1 Year Change | -34.23% |
3 Year Change | -74.29% |
5 Year Change | -75.39% |
Change since IPO | -79.27% |
Recent News & Updates
Recent updates
Shareholder Returns
8C4 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -5.2% | -0.6% | 1.6% |
1Y | -34.2% | 2.8% | 6.4% |
Return vs Industry: 8C4 underperformed the German Medical Equipment industry which returned 2.8% over the past year.
Return vs Market: 8C4 underperformed the German Market which returned 6.4% over the past year.
Price Volatility
8C4 volatility | |
---|---|
8C4 Average Weekly Movement | 7.3% |
Medical Equipment Industry Average Movement | 5.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8C4 has not had significant price volatility in the past 3 months.
Volatility Over Time: 8C4's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 257 | Yoshiyuki Sankai | https://www.cyberdyne.jp |
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high-speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance and regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; Neuro HALFIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes’ brain-nerve functions; and Neuro HALFIT at home for enhancement of physical functions.
CYBERDYNE Inc. Fundamentals Summary
8C4 fundamental statistics | |
---|---|
Market cap | €273.56m |
Earnings (TTM) | -€8.01m |
Revenue (TTM) | €25.15m |
10.9x
P/S Ratio-34.1x
P/E RatioIs 8C4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8C4 income statement (TTM) | |
---|---|
Revenue | JP¥4.13b |
Cost of Revenue | JP¥2.08b |
Gross Profit | JP¥2.05b |
Other Expenses | JP¥3.37b |
Earnings | -JP¥1.32b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
Earnings per share (EPS) | -6.24 |
Gross Margin | 49.61% |
Net Profit Margin | -31.86% |
Debt/Equity Ratio | 0.3% |
How did 8C4 perform over the long term?
See historical performance and comparison